Clinical Trial Update: Immunogenicity and Safety of Pneumococcal Vaccination in Patients Treated With Immune Checkpoint Inhibitors

View source ↗

Summary

The clinical trial evaluating immunogenicity and safety of pneumococcal vaccination in patients treated with immune checkpoint inhibitors for melanoma or non-sm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma
• Non-small Cell Lung Cancer

Drugs mentioned

• Immune checkpoint inhibitors (immune checkpoint inhibitor)
• Pneumococcal vaccine (pneumococcal vaccine)

Snippet

Sponsor: University of Cologne | Conditions: Melanoma, Non Small Cell Lung Cancer | Status: WITHDRAWN